Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Medicine|November 2, 2018
The prognostic value of lymph node ratio for local advanced gastric cancer patients with adjuvant chemoradiotherapy after D2 gastrectomyMin Hu, Shu Zhang, Xue Yang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Lung tumor reproducibility with active breath control (ABC) in image-guided radiotherapy based on cone-beam computed tomography with two registration methodsXin Wang, Renming Zhong, Sen Bai, et al.
Thoracic Cancer|September 19, 2017
nm23-H1 gene driven by hTERT promoter induces inhibition of invasive phenotype and metastasis of lung cancer xenograft in miceYu Fan, Yibing Yao, Lu Li, et al.
Oncology Letters|December 2, 2015
NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patientsXiaoyu Li, Fuchun Guo, Yongmei Liu, et al.
Innovation (Cambridge (Mass.))|July 9, 2026
Unmasking hidden high risk in RUNX1::RUNX1T1 pediatric AML: Development of a novel prognostic modelYang Xun, Yali Shen, Hua Yang, et al.
Oncology Letters|March 16, 2018
High expression of PRPS1 induces an anti-apoptotic effect in B-ALL cell lines and predicts an adverse prognosis in Chinese children with B-ALLYimei Ma, Xizhou An, Xianmin Guan, et al.
American Journal of Hematology|July 1, 2026
Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B-ALLBinjun Xiong, Jianwen Zhou, Xuhan Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 22, 2008
The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancerJin Wang, Sen Bai, Nianyong Chen, et al.
Cell Reports. Medicine|October 4, 2024
A simplified and robust risk stratification model for stem cell transplantation in pediatric acute myeloid leukemiaHua Yang, Yang Xun, Yali Shen, et al.
Urologic Oncology|February 18, 2026
Efficacy of disitamab vedotin-based therapy in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: A systematic review and meta-analysisJianjun Ye, Yanxin Li, Mengni Zhang, et al.
Pageof 8